When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Embolic and thrombotic events after COVID-19 vaccination

   en.wikipedia.org/wiki/Embolic_and_thrombotic...

   The thrombosis events associated with the COVID‑19 vaccine may occur 4–28 days after its administration and mainly affects women under 55. [6] [2] [20] Several relatively unusual types of thrombosis were specifically reported to be occurring in those with the reaction: cerebral venous sinus thrombosis and thrombosis of the splanchnic veins.

3. Pfizer–BioNTech COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Pfizer–BioNTech_COVID-19...

   The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [45][46] It is authorized for use ...

4. COVID-19 in pregnancy - Wikipedia

   en.wikipedia.org/wiki/COVID-19_in_pregnancy

   COVID-19 pandemic. COVID-19 infection in pregnancy is associated with several pregnancy complications. [1] However, pregnancy does not appear to increase the susceptibility of becoming infected by COVID-19. [2] Recommendations for the prevention of COVID-19 include the same measures as non-pregnant people. [3]

5. Pfizer to begin Covid vaccine clinical trial in pregnant women

   www.aol.com/news/pfizer-begin-covid-vaccine...

   The drugmaker aims to enroll 4,000 expectant mothers. Pfizer-BioNTech said Thursday that it is beginning clinical trials of its Covid-19 vaccine in pregnant women, the first such trials to include ...

6. CDC recommends pregnant women get COVID-19 vaccine - AOL

   www.aol.com/news/cdc-recommends-pregnant-women...

   (Reuters) -Pregnant women should be vaccinated against COVID-19, based on a new analysis that did not show increased risk for miscarriage, the U.S. Centers for Disease Control and Prevention said ...

7. Nirmatrelvir/ritonavir - Wikipedia

   en.wikipedia.org/wiki/Nirmatrelvir/ritonavir

   In May 2022, Pfizer suggested repeating the treatment, but the FDA said there was no evidence of benefit. [38] [39] In June 2022, a US case report of ten people with rebound COVID‑19 had found viral load during relapse was comparable to levels during an initial infection, and high enough to cause secondary transmission. [40]